Source: Pharmacy Times articles
Study shows a significant decline in breast cancer mortality across multiple subtypes.
Read More
Recent Content
- Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
- TAR-200 Shows High Response Rates in Bladder Cancer Subset
- A Fellow Cancer Survivor Gives Me a Useful Message
- AACR 2025: Tailored Treatment Guided by Combined Tissue and Liquid Biopsies May Improve Outcomes in Advanced Solid Tumors
- FDA Approves Upadacitinib for Adult Patients With Giant Cell Arteritis
- FDA Approves Prademagene Zamikeracel, First and Only Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
- Balancing Efficacy and Value for Cell and Gene Therapy Through Value-Based Pricing
- Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP
- Hyperglycemia in HR+ Breast Cancer: Prevention and Management Strategies for Oncology Pharmacists
- FDA Approves Ready-to-Dilute Tepylute for Breast and Ovarian cancer